Sign in
Not yet recruitingNo phase

The PRECISE-DIET Trial

Key facts

Who runs it
Steno Diabetes Center Copenhagen
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
130 people, planned
Starts
Feb 2027
Expected to end
Mar 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Personalised dietary intervention
  • Standard dietary counselling
Record updated
16 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • T2D
  • Diabetes duration of ≥12 months
  • Age ≥18 years
  • HbA1c ≥58 mmol/mol
  • Attending the SDCC outpatient clinic
  • Provided voluntary signed informed consent

Who cannot take part

  • Use of insulin therapy
  • Low daily carbohydrate intake (defined as below 25 E% or 100 g/day) prior to study inclusion
  • Systematic use of corticosteroids
  • Known or suspected drug or alcohol abuse
  • Initiation of GLP-1 receptor agonist or SGLT inhibitor therapy within the previous 3 months
  • Using or requiring a specialised diet (e.g., protein restriction in kidney disease)
  • Medical complications that prevent lowering HbA1c to below 58 mmol/mol
  • Circumstances that affect HbA1c (e.g., liver disease and anaemia)
  • Inability to understand the study information
  • Pregnancy or breastfeeding or plans of pregnancy within the study period
  • Participation in other clinical trials
  • Individuals with a BMI of <27 kg/m²

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

People with type 2 diabetes receive standard dietary advice to improve glycaemic control. However, blood glucose responses to the same foods can vary considerably between individuals. This randomised controlled trial aims to investigate whether personalised carbohydrate recommendations guided by continuous glucose monitoring (CGM) improve glycaemic control (HbA1c) compared with standard dietary care.

Read full original descriptionShow less

A total of 130 adults with type 2 diabetes will be randomly assigned to one of two groups. The study will include a 6-month intervention period followed by a 6-month follow-up period. The intervention group will receive dietitian-led personalised carbohydrate recommendations informed by CGM data, supplemented by group-based education in carbohydrate counting. The control group will receive standard individual dietary counselling provided by a dietitian without the use of CGM.

The primary outcome is the between-group difference in change in HbA1c from baseline to 6 months.

The 2 groups in the trial

  • Personalised dietary interventionTreatment being tested

    CGM-supported personalised carbohydrate recommendations

  • Standard dietary counsellingExisting treatment, for comparison

    Standard dietary counselling for type 2 diabetes

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Precision Nutrition Versus Standard Dietary Care: Effect of Personalised Nutrition Guidance Based on Continuous Glucose Monitoring in Type 2 Diabetes - The PRECISE-DIET Trial
Record updated
16 November 2026